Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-01 21:09:24 - browse：3242

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： The system is set up to fail children with medical complexity

WSS

Biogen nominates mother of director’s child to replace him on board

Curing rare childhood diseases will falter unless Congress steps up

Bispecific antibodies are next new thing in cancer immunotherapy

Novo: Oral version of Ozempic leads to 15% weight loss

NIH tests clinical research in primary care with $30 million program

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

hotspot

Wikipedia

Wikipedia

The high cost of giving birth even with insurance

How to fix the rural physician shortage in the U.S.

Virginia high school admissions case could be legal follow

Xenotransplantation trials will require adjusting expectations, experts say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biogen nominates mother of director’s child to replace him on board

Continuity nursing helped my family in our darkest PICU moments

'Essentially witchcraft:' A former naturopath takes on the field

The high cost of giving birth even with insurance

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

leisure time

Biogen nominates mother of director’s child to replace him on board

Statins may not be needed by millions of people, study suggests

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Timeline: Key moments in fight for gay rights

How faith leaders like me can help address America's obesity epidemic

Biden administration plans revamp of organ transplant system

focus

explore

hotspot

knowledge